Treatment with personalised neoantigen DNA vaccines is feasible, says a clinical-trial-based study published in Genome ...
A new phase 1 trial demonstrates the safety and effectiveness of personalized neoantigen DNA vaccines, showing promising ...
A small clinical trial shows promising results for patients with triple-negative breast cancer who received an ...
Neoantigen DNA vaccines are safe and capable of inducing neoantigen-specific immune responses in patients with ...
After surgery, the team analyzed and compared the tumor tissue with the healthy tissue of the same patient to find unique ...
Shares in biotech firm Moderna (NASDAQ:MRNA) rose more than 4% Monday after HSBC raised its rating on the stock from Hold to ...
A clinical trial at WashU Medicine shows promising results for a personalized vaccine designed to prevent recurrence in triple-negative breast cancer patients.
A small clinical trial shows promising results for patients with triple-negative breast cancer who received an ...
Compelling 24.1-month median follow-up data presented at SITC 2024 showed that all patients treated with TG4050 after completion of an adjuvant ...
News Medical on MSN5d
New vaccine shows potential in preventing recurrence of triple-negative breast cancerA small clinical trial shows promising results for patients with triple-negative breast cancer who received an investigational vaccine designed to prevent recurrence of tumors.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback